Literature DB >> 12030548

The presence and severity of vertebral fractures is associated with the presence of esophageal hiatal hernia in postmenopausal women.

T Yamaguchi1, T Sugimoto, H Yamada, M Kanzawa, S Yano, M Yamauchi, K Chihara.   

Abstract

We examined the relationship between the presence of esophageal hiatal hernia (HH) assessed by endoscopy and the presence of vertebral fractures (VFs) in 87 Japanese postmenopausal women (age range 52-87 years). We found that 29 (63%) of 46 patients with HH (71.2+/-6.1 years, mean +/- SD) had one or more VFs, compared with 14 (34%) of 41 patients without HH (70.8+/-6.8 years), which was a significant difference in the frequency of VFs (c2 = 7.242; p = 0.0071). The average number of VFs per patient was significantly higher for the patients with HH than for those without HH (1.67+/-1.75 vs 0.68+/-1.21, p = 0.0032). There were no significant differences in absolute or age-matched bone mineral density (BMD) values at the lumbar spine (0.656+/-0.131 vs 0.662+/-0.148 g/cm2; Z-score, -0.35+/-1.17 vs -0.26+/-1.00) and there were no significant differences in biochemical parameters, age, years since menopause or body mass index (BMI) between the two groups. When patients were divided into those with reflux esophagitis (RE) (n = 30, 70.2+/-7.3 years) and those without RE (n = 57, 71.4+/-5.9 years), no significant differences were detected in any of the above parameters including the presence or number of VFs. The patients were further subdivided into four groups: those with 'HH only' (n = 23, 72.3+/-4.6 years), with 'RE only' (n = 7, 70.9+/-7.7 years), with 'both' (n = 23, 70.0+/-7.3 years) and with 'neither' (n = 34, 70.8+/-6.7 years). One or more VFs were found in 12 (52%), 1 (14%), 17 (74%), and 13 (38%) patients in each group, respectively, and the difference in frequency was significant (c2 = 10.748; p = 0.0132). The average number of VFs per patient in each group was 1.57+/-2.06, 0.14+/-0.38, 1.78+/-1.41 and 0.79+/-1.30, respectively, and there were significant differences between the 'both' and 'neither' groups, and between the 'both' and 'RE only' groups (p<0.05). When univariate logistic regression analysis was performed with the presence of HH as a dependent variable and each of the presence of VFs, the number of VFs per patient, absolute or age-matched BMD values at the lumbar spine, BMI and plasma albumin as independent variables, the presence of VFs and the number of VFs per patient were selected as indices affecting the presence of HH (odds ratio: 3.29 and 1.59, 95% confidence interval: 1.36-7.94 and 1.14-2.23; p=0.0080 and 0.0064, respectively). These results show that the presence and severity of VFs are associated with the presence of HH but not of RE in Japanese postmenopausal women, and suggest that kyphosis induced by multiple VFs might predispose elderly women to a complication with HH.

Entities:  

Mesh:

Year:  2002        PMID: 12030548     DOI: 10.1007/s001980200034

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  17 in total

1.  Impact of adult spinal deformity corrective surgery in patients with the symptoms of gastroesophageal reflux disease: a 5-year follow-up report.

Authors:  Tomohiko Hasegawa; Hiroki Ushirozako; Yu Yamato; Daisuke Togawa; Go Yoshida; Sho Kobayashi; Tatsuya Yasuda; Tomohiro Banno; Hideyuki Arima; Shin Oe; Tomohiro Yamada; Koichiro Ide; Yuh Watanabe; Yukihiro Matsuyama
Journal:  Eur Spine J       Date:  2020-01-25       Impact factor: 3.134

2.  Maintenance therapy of gastroesophageal reflux disease.

Authors:  Akihito Nagahara; Mariko Hojo; Daisuke Asaoka; Sumio Watanabe
Journal:  Clin J Gastroenterol       Date:  2010-02-19

3.  Comparison of once-weekly teriparatide and alendronate against new osteoporotic vertebral fractures at week 12.

Authors:  Satoshi Ikeda; Eiichiro Nakamura; Kenichiro Narusawa; Fumio Fukuda; Hidehiro Matsumoto; Kenichiro Nakai; Takeshi Sakata; Toru Yoshioka; Yoshihisa Fujino; Akinori Sakai
Journal:  J Bone Miner Metab       Date:  2019-07-11       Impact factor: 2.626

4.  Gastro-esophageal reflux disease: the recent trend in Japan.

Authors:  Hiroto Miwa; Tadayuki Oshima; Toshihiko Tomita; Yongmin Kim; Kazutoshi Hori; Takayuki Matsumoto
Journal:  Clin J Gastroenterol       Date:  2008-12-02

5.  Height loss in elderly women is preceded by osteoporosis and is associated with digestive problems and urinary incontinence.

Authors:  J Berecki-Gisolf; M Spallek; R Hockey; A Dobson
Journal:  Osteoporos Int       Date:  2009-07-14       Impact factor: 4.507

6.  The demographic characteristics and health-related quality of life in a large cohort of reflux esophagitis patients in Japan with reference to the effect of lansoprazole: the REQUEST study.

Authors:  Michio Hongo; Yoshikazu Kinoshita; Hiroto Miwa; Kiyoshi Ashida
Journal:  J Gastroenterol       Date:  2008-12-24       Impact factor: 7.527

7.  Impact of spinal kyphosis on gastroesophageal reflux disease symptoms in patients with osteoporosis.

Authors:  N Miyakoshi; Y Kasukawa; H Sasaki; K Kamo; Y Shimada
Journal:  Osteoporos Int       Date:  2008-10-23       Impact factor: 4.507

8.  Overweight and underweight are risk factors for vertebral fractures in patients with type 2 diabetes mellitus.

Authors:  Ippei Kanazawa; Masakazu Notsu; Ayumu Takeno; Ken-Ichiro Tanaka; Toshitsugu Sugimoto
Journal:  J Bone Miner Metab       Date:  2018-09-20       Impact factor: 2.626

9.  Influence of lumbar kyphosis and back muscle strength on the symptoms of gastroesophageal reflux disease in middle-aged and elderly people.

Authors:  Shiro Imagama; Yukiharu Hasegawa; Norimitsu Wakao; Kenichi Hirano; Nobuyuki Hamajima; Naoki Ishiguro
Journal:  Eur Spine J       Date:  2012-02-28       Impact factor: 3.134

10.  Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?

Authors:  Daisuke Asaoka; Akihito Nagahara; Yuji Shimada; Kenshi Matsumoto; Hiroya Ueyama; Kohei Matsumoto; Yuta Nakagawa; Tsutomu Takeda; Ippei Tanaka; Hitoshi Sasaki; Taro Osada; Mariko Hojo; Sumio Watanabe
Journal:  Ther Clin Risk Manag       Date:  2015-03-06       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.